Adverse Events Associated With Antibody-Drug Conjugates Across Cancer Types
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Diagnosis & Disease Information
Increased Exposure to PFAS, Phenols, and Parabens Linked to Prior Cancer Diagnosis
Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.
HIPEC Improves Long-Term Outcomes in Stage III Ovarian Cancer
Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in stage III epithelial ovarian cancer, a phase 3 trial suggests.
Atezolizumab Does Not Improve PFS in Recurrent, Platinum-Sensitive Ovarian Cancer
Adding atezolizumab to bevacizumab and platinum-based chemotherapy did not improve PFS in recurrent, platinum-sensitive ovarian cancer.
Intervention Enables Same-Day Genetic Testing for Ovarian Cancer Patients
A genetic testing station can increase uptake and improve the efficiency of genetic testing for patients with ovarian cancer, a study suggests.
The Challenge of Making Cancer Trials More Diverse
Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse.
Screening Confers “Small” Survival Benefit in High-Grade Serous Ovarian Cancer
Screening can lead to earlier diagnosis of high-grade serous ovarian cancer, but this does not translate to a substantial improvement in survival, according to researchers.
Cancer Patients With ICI-Induced Acute Pancreatitis May Require Imaging, Monitoring
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Antibody-Drug Conjugates Pose Risk of Ocular Adverse Effects
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
Bariatric Surgery Linked to Lower Cancer Incidence, Death Among Women
Researchers found a lower incidence of cancer and a lower risk of cancer death among women who underwent bariatric surgery.
- Loading...
Loading...
Loading... 
Loading...